文献速递临床试验与 GCP

血栓弹力测量法与标准凝血试验及限制性方案指导肝硬化患者中心静脉置管前输血:一项随机对照试验的研究方案

Thromboelastometry versus standard coagulation tests versus restrictive protocol to guide blood transfusion prior to central venous catheterization in cirrhosis: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-02-27

本研究为在巴西圣保罗一家三级私立医院开展的双盲、平行组、单中心随机对照试验,纳入入住重症监护室需行中心静脉置管的成人肝硬化患者,比较标准凝血试验指导、血栓弹力测量法指导或限制性输血三种策略在置管前输血中的效果。主要疗效终点为置管前接受任何血制品输血的患者比例,主要安全性终点为大出血发生率。作者假设血栓弹力测量法和/或限制性方案安全且可显著减少血制品输注,从而降低成本及输血相关不良反应。

要点

  • 纳入成人肝硬化入住重症监护室且需中心静脉置管的患者,随机分为标准凝血试验指导、血栓弹力测量法指导或限制性输血三组。
  • 主要疗效终点为置管前接受任何血制品输血的患者比例,主要安全性终点为大出血发生率。
  • 作者假设血栓弹力测量法和/或限制性方案安全且可显著减少血制品输注,降低成本及输血相关不良反应。

核心结论

  • 本研究将评估三种指导肝硬化重症患者中心静脉置管前输血的策略,作者假设血栓弹力测量法和/或限制性方案安全且可显著减少血制品输注,从而降低成本及输血相关不良反应。

研究设计与样本

  • 双盲、平行组、单中心、随机对照临床试验,在巴西圣保罗一家三级私立医院开展。
  • 纳入标准为年龄18岁及以上、入住重症监护室、患有肝硬化且有中心静脉置管指征的成人患者。
  • 患者被随机分配到三个组,分别接受基于标准凝血试验、基于血栓弹力测量法或限制性的置管前输血策略。

主要发现

  • 主要疗效终点为置管前接受任何血制品输血的患者比例。
  • 主要安全性终点为大出血发生率。
  • 次要终点包括新鲜冰冻血浆、血小板和冷沉淀的输注比例;血制品输注量;操作前后血红蛋白和血细胞比容;重症监护室和住院时间;28天死亡率和住院死亡率;轻微出血发生率;输血相关不良反应;以及成本分析。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Liver failure patients have traditionally been empirically transfused prior to invasive procedures. Blood transfusion is associated with immunologic and nonimmunologic reactions, increased risk of adverse outcomes and high costs. Scientific evidence supporting empirical transfusion is lacking, and the best approach for blood transfusion prior to invasive procedures in cirrhotic patients has not been established so far. The aim of this study is to compare three transfusion strategies (routine coagulation test-guided - ordinary or restrictive, or thromboelastometry-guided) prior to central venous catheterization in critically ill patients with cirrhosis. METHODS/DESIGN: Design and setting: a double-blinded, parallel-group, single-center, randomized controlled clinical trial in a tertiary private hospital in São Paulo, Brazil. INCLUSION CRITERIA: adults (aged 18 years or older) admitted to the intensive care unit with cirrhosis and an indication for central venous line insertion. Patients will be randomly assigned to three groups for blood transfusion strategy prior to central venous catheterization: standard coagulation tests-based, thromboelastometry-based, or restrictive. The primary efficacy endpoint will be the proportion of patients transfused with any blood product prior to central venous catheterization. The primary safety endpoint will be the incidence of major bleeding. Secondary endpoints will be the proportion of transfusion of fresh frozen plasma, platelets and cryoprecipitate; infused volume of blood products; hemoglobin and hematocrit before and after the procedure; intensive care unit and hospital length of stay; 28-day and hospital mortality; incidence of minor bleeding; transfusion-related adverse reactions; and cost analysis. DISCUSSION: This study will evaluate three strategies to guide blood transfusion prior to central venous line placement in severely ill patients with cirrhosis. We hypothesized that thromboelastometry-based and/or restrictive protocols are safe and would significantly reduce transfusion of blood products in this population, leading to a reduction in costs and transfusion-related adverse reactions. In this manner, this trial will add evidence in favor of reducing empirical transfusion in severely ill patients with coagulopathy. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT02311985 . Retrospectively registered on 3 December 2014.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Rocha LL, Pessoa CM, Neto AS, et al. Thromboelastometry versus standard coagulation tests versus restrictive protocol to guide blood transfusion prior to central venous catheterization in cirrhosis: study protocol for a randomized controlled trial. Trials. 2017. PMID: 28241780. doi:10.1186/s13063-017-1835-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。